ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0779

Fatty Acid Synthase Promotes Podocyte and Mesangial Cell Injury in Lupus Nephritis

Session Information

Category: Glomerular Diseases

  • 1401 Glomerular Diseases: Mechanisms, including Podocyte Biology

Authors

  • Zhou, Hua, Department of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China
  • Wang, Zhiduo, Department of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China
  • Zhang, Yonghe, Department of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China
  • Luan, Junjun, Department of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China
Background

High proportion of Lupus nephritis (LN) patients progress to end stage kidney disease due to the insufficient understanding of its mechanisms. Recent study reports that reducing renal lipid accumulation can ameliorate several kidney diseases. We aim to clarify whether fatty acid synthase (FASN) promotes podocyte and mesangial cell injury in lupus nephritis through reducing lipid accumulation in kidneys.

Methods

FASN expression in LN patients' kidneys predicted by bioinformatic analysis. Renal tissue of LN patients and Fcgr2b-/- spontaneous LN mice were applied for in vivo study. Mesangial cells and podocytes were used for in vitro study including overexpression or knockdown of FASN. Oil Red O staining on kidney sections from LN patients and LN model mice was used to examine renal lipid accumulation in vivo. BODIPY lipid fluorescence staining to analyze intracellular lipid accumulation in vitro. PAS and Masson's trichrome staining were employed to assess glomerular injury and fibrosis. Western blotting and immunofluorescence staining were conducted to examine the expression of FASN, mesangial cell marker ITGA8, podocyte injury markers (WT-1 and podocin), as well as fibrosis markers (FN and COL1).

Results

FASN increased in mesangial cells and podocytes of glomeruli of LN patients, meanwhile Oil Red O positive lipid droplet accumulation was seen in glomeruli. In Fcgr2b-/- spontaneous LN, mesangial cells increased and podocyte vacuolar changes and detachment showed on PAS staining, and glomerulosclerosis was seen on Masson's trichrome staining. FASN increased in LN mice glomeuli on Western Blotting and immunofluorescent staining. Oil Red O positive staining was also seen in LN mouse glomeruli. At same time, WT-1 and podocin decreased, ITGA8 increased, and FN and COL1 increased. In mesangial cells and podocytes with hTGF-β stimulation, similar results were seen as in vivo. In addition, overexpression of FASN in both mesangial cells and podocytes, FASN, lipid accumulation, and cell type specific molecules and profibrotic molecules showed same change direction as LN glomerular cells as well as BODIPY lipid fluorescence staining extend. Meanwhile, these molecular changes induced by hTGF-βwere reversed by FASN knockdown using siRNA.

Conclusion

FASN may cause mesangial cells proliferation and podocytes injury in LN kidney by promoting lipid synthesis and accumulation.

Funding

  • Government Support – Non-U.S.

Digital Object Identifier (DOI)